Evidence map›Paper›PMID 24430575›Full record

ArticleJournal of human genetics2014

Association of miR-146a gene polymorphism with risk of nasopharyngeal carcinoma in the central-southern Chinese population.

Guo-Liang Huang, Mei-Ling Chen, Ya-Zhen Li, Yan Lu, Xing-Xiang Pu, Yu-Xiang He, Shu-Yin Tang, Hua Che, Ying Zou, Congcong Ding and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 4 pooled it
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 4 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Bioscience reports · 2018
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Guo-Liang Huang1] Sino-American Cancer Research Institute, Guangdong Medical College, Dongguan, China [2] Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China.
Mei-Ling ChenInstitute Of Laboratory Medicine, Guangdong Medical College, Dongguan, China.
Ya-Zhen LiInstitute Of Laboratory Medicine, Guangdong Medical College, Dongguan, China.
Yan Lu1] Sino-American Cancer Research Institute, Guangdong Medical College, Dongguan, China [2] Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China.
Xing-Xiang PuDepartment of Medical Oncology, Hunan Tumor Hospital, Changsha, China.
Yu-Xiang HeDepartment of Oncology, Central South University Xiangya Hospital, Changsha, China.
Shu-Yin TangInstitute Of Laboratory Medicine, Guangdong Medical College, Dongguan, China.
Hua CheInstitute Of Laboratory Medicine, Guangdong Medical College, Dongguan, China.
Ying Zou1] Sino-American Cancer Research Institute, Guangdong Medical College, Dongguan, China [2] Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China.
Congcong Ding1] Sino-American Cancer Research Institute, Guangdong Medical College, Dongguan, China [2] Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China.
Zhiwei He1] Sino-American Cancer Research Institute, Guangdong Medical College, Dongguan, China [2] Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Dongguan, China.
Guangdong Medical College · CNKey Laboratory of Guangdong Province · CNCentral South University · CNHunan Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case-control study focused on estimating the association between miR-146a polymorphism and risk of nasopharyngeal carcinoma (NPC) in central-south China. In total, 160 patients with NPC and 200 healthy controls in central-south China were genotyped using polymerase chain reaction-restriction fragment length polymorphism assay. Chi-square test was used to assess the different distribution of miR-146a polymorphism between NPC patients and controls; and logistic regression analysis was applied to analyze the associations between miR-146a polymorphism with cancer risk in different contrast models. Significant differences between NPC patients and controls were found in genotype (P=0.033 for GG versus CG versus CC; and odds ratio (OR)=0.568, 95% confidence interval (CI)=0.354-0.912, P=0.019 for CG versus CC; and OR=0.503, 95% CI=0.261-0.971, P=0.041 for CG versus CC; and OR=0.564, 95% CI=0.360-0.884, P=0.012 for GG+CG versus CC, respectively) and allelic analysis (P=0.025 for G versus C). Our findings suggested that polymorphism of mir-146a was associated with NPC in the central-southern Chinese population.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAdultAsian PeopleCarcinomaCase-Control StudiesChinaFemaleGene FrequencyHumansMaleMicroRNAsMiddle AgedNasopharyngeal CarcinomaNasopharyngeal NeoplasmsPolymorphism, Single NucleotideMicroRNAsMIRN146 microRNA, human

Identifiers

PMID24430575
OpenAlexW1990034637

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.